Healthcare Archives - Feedback

Healthcare

Rajasthan-based RUJ Group has announced its foray into the hospital space. Announcing plans for a 150-bed multi-super-specialty hospital in Jaipur. RUJ Hospitals Pvt Ltd would invest Rs. 150- 200 crore over the next two years for the hospital. The hospital, which will be ready in two years, will provide specialty healthcare services, including critical care, CTVS, […]

Healthians, a diagnostics start-up is planning expansion into southern India with a planned outlay of Rs. 50 crore. The start-up, which began operations in 2015 and backed by cricketer Yuvraj Singh’s investment venture YouWeCan and Asuka Holdings amongst others, has launched its first pathology lab in Bengaluru, as part of the expansion plan. https://www.thehindubusinessline.com/todays-paper/tp-others/tp-states/article25997604.ece

Indoco Remedies is in initial discussions with investors such as Zydus Cadila and Lupin, along with private equity funds including TPG Capital Management and Temasek Holdings to sell part of its domestic business in a deal valued at Rs 500-600 crore. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/indoco-in-talks-to-sell-part-of-india-operations/articleshow/67549954.cms

Fortis Healthcare it has completed the acquisition of RHT Health Trust (RHT) assets. In February last year, Fortis had announced that it has entered into definitive agreements with RHT to acquire entire portfolio of assets of the Singapore-listed entity for an enterprise value of Rs 4,650 crore. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/fortis-completes-acquisition-of-rht-assets/articleshow/67546847.cms

Health-tech platform Medlife is planning to expand its presence in the retail pharmacy segment by opening around 750 pharmacies across the country in two years. The company, which is a leading player in the online pharmacy segment, is mainly looking at acquisitions to achieve the target. https://www.business-standard.com/article/companies/medlife-plans-to-open-750-retail-pharmacies-across-india-by-2020-end-119011300096_1.html

US-drug maker Pfizer will be shutting down two of its facilities in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing non-viability of operations. The closures will affect 1700 employed at both locations of the company which has a total of five manufacturing sites across the country. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-to-stop-manufacturing-in-its-chennai-and-aurangabad-facilities/articleshow/67456313.cms

Mumbai-based health-tech startup Vantage Health [VH] has raised $50 million in a funding round from Cayman Islands-based fund IQGEN Holdings LLC. The four-month-old company which looks at launching a data-driven healthcare system would use the funds to support the operations and technology development. https://www.business-standard.com/article/companies/health-tech-startup-vantage-health-raises-50-million-from-iqgen-holdings-119010700974_1.html

India is getting ready for a project that is as small as it gets — and as big. The Human Microbiome Project (HMP) will map trillions upon trillions of microbes — bacteria, fungi, viruses, archaea — that are found in Indians. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/india-gears-up-for-rs-150-crore-microbe-project-to-uncover-links-to-diseases/articleshow/67397830.cms

Drug major Sun Pharma has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100 % shares of Pola Pharma Inc Japan by the company’s wholly owned subsidiary has been concluded. https://www.business-standard.com/article/companies/sun-pharma-acquires-japan-s-pola-pharma-to-expand-in-dermatology-segment-119010300702_1.html

Bristol-Myers Squibb Co would buy Celgene Corp for about $74 billion, combining two of the world’s largest cancer drug businesses in the biggest pharmaceutical deal ever. Both Bristol-Myers and Celgene face separate challenges, and some Wall Street analysts questioned whether the combination – which the companies said would create $2.5 billion in cost savings and […]